Comparison of Core Stability, Body Awareness, Pelvic Health, Sleep, and Quality of Life in Physically Active Women With and Without Polyendocrine Metabolic Ovarian Syndrome
2026年8月5日 更新者：Ezgi Türkmen、Health Institutes of Turkey
Aim of the study was to compare physically active women with and without Polyendocrine Metabolic Ovarian Syndrome (PMOS) in terms of core stability, body awareness, pelvic health, sleep, and quality of life, and to reveal the possible effects of the presence of PMOS on these parameters despite physical activity.
調査の概要
詳細な説明
The study plans to include female participants who have been regularly practicing Pilates at least twice a week for at least three months at a designated Pilates studio.
Data on participants' socio-demographic characteristics, core stability, body awareness, pelvic floor function, sleep, and quality of life will be collected.
This research study is designed as an observational and cross-sectional evaluation study.
研究の種類
観察的
入学 (推定)
50
連絡先と場所
このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。
研究連絡先
- 名前：Ezgi Türkmen
- 電話番号：0090 216 547 26 00
- メール：turkmnezgi@gmail.com
研究場所
-
-
-
Istanbul、トルコ（Türkiye）
- 募集
- Haliç Üniversitesi
-
コンタクト：
- Ayşenur Çetinkaya
- 電話番号：0090 212 924 24 44
- メール：aysenurcetinkaya@halic.edu.tr
-
-
参加基準
研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。
適格基準
就学可能な年齢
- 大人
健康ボランティアの受け入れ
いいえ
サンプリング方法
非確率サンプル
調査対象母集団
Participants with Polyendocrine Metabolic Ovarian Syndrome & Healthy Adults
説明
Inclusion Criteria:
- Being a woman aged 18-40 with a diagnosis of PMOS (n=25).
- Being a healthy woman aged 18-40 (n=25).
- Having practiced Pilates regularly for at least three months, at least twice a week.
- Voluntarily agreeing to participate in the study.
Exclusion Criteria:
- Being pregnant or in the first 6 months postpartum.
- Being in menopause.
- Having any other diagnosed gynecological pathology.
- Having any significant physical limitations that would prevent the tests from being performed.
- Having any diagnosed psychological disorder that would hinder communication.
研究計画
このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。
研究はどのように設計されていますか？
デザインの詳細
コホートと介入
グループ/コホート |
|---|
|
Group I
Paricipants with Polyendocrine Metabolic Ovarian Syndrome
|
|
Group II
Healthy Adult Participants
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Forearm Plank Test
時間枠：Baseline
|
The purpose of this test is to measure the core stability, or endurance, of the trunk muscles.
Participants are asked to keep their body in a straight line against gravity with their forearms on the ground and their toes touching the ground, and to maintain their posture without changing position by contracting their abdominal muscles.
The time (in seconds) spent in this position is measured and recorded with a stopwatch.
|
Baseline
|
|
Side Bridge Test
時間枠：Baseline
|
The participant lies on their side with their elbow and forearm placed on the ground at shoulder level.
Legs and feet are placed on top of each other, forming a straight line.
The individual lifts their hips off the ground against gravity, bringing their body into a side bridge position parallel to the ground.
Both sides (right/left) are tested separately.
The time (in seconds) spent in this position is measured and recorded with a stopwatch.
|
Baseline
|
|
Body Awareness Questionnaire (BAQ)
時間枠：Baseline
|
BAQ is an 18-item self-report scale designed to measure how attentive the participants are to normal, non-emotional internal bodily processes.
It evaluates the sensitivity to everyday bodily cycles (like sleep and hunger), ability to detect subtle changes, and capacity to anticipate physical reactions.
Typically takes about 3 to 5 minutes.
Items are generally rated on a 1 to 7 scale, with higher total scores indicating greater perceived condence and accuracy in monitoring the physical state over time.
|
Baseline
|
|
Pelvic Floor Distress Inventory-20 (PFDI-20)
時間枠：Baseline
|
This scale, which assesses pelvic floor-related symptoms and pelvic functionality, consists of three subscales: POPDI-6, CRADI-8, and UDI-6.
The average of the responses for each subscale is calculated and multiplied by 25 to create a standard score on a scale of 0-100 for each subscale.
The total PFDI-20 score is obtained by summing the scores of the three subscales and ranges from 0 to 300.
Higher scores indicate more symptoms and discomfort.
|
Baseline
|
|
Pittsburgh Sleep Quality Index (PSQI)
時間枠：Baseline
|
This scale was developed to assess sleep quality and disturbances over a one-month period.
The 18 items included in the scoring are grouped into 7 components.
Some components are represented by a single item, while others are obtained by combining several items.
Each item is rated on a scale of 0-3, and the scores of each component are added together to obtain a total score between 0-21.
A higher total score indicates poor sleep quality, while a score above 5 generally indicates poor sleep quality.
|
Baseline
|
|
WHO - Quality of Life - Brief (WHOQOL-BREF)
時間枠：Baseline
|
The World Health Organization-developed quality of life assessment tool helps evaluate an individual's overall health status.
It consists of 26 questions, each scored on a 5-point Likert scale from 1 (very poor) to 5 (very good).
The scale covers four core areas of life: physical health, psychological health, social relationships, and environment.
It also includes two additional items that assess an individual's overall quality of life and health satisfaction.
Raw scores are converted into a total score on a scale of 0-100 using a formula.
Higher scores indicate a higher perceived quality of life.
|
Baseline
|
協力者と研究者
ここでは、この調査に関係する人々や組織を見つけることができます。
研究記録日
これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。
主要日程の研究
研究開始 (実際)
2026年8月5日
一次修了 (推定)
2026年9月1日
研究の完了 (推定)
2026年9月1日
試験登録日
最初に提出
2026年7月27日
QC基準を満たした最初の提出物
2026年7月30日
最初の投稿 (実際)
2026年8月5日
学習記録の更新
投稿された最後の更新 (実際)
2026年8月6日
QC基準を満たした最後の更新が送信されました
2026年8月5日
最終確認日
2026年8月1日
詳しくは
本研究に関する用語
キーワード
その他の研究ID番号
- ETurkmen0426
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
いいえ
米国FDA規制機器製品の研究
いいえ
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。